Literature DB >> 8993004

Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase.

V del Pozo1, E de Arruda-Chaves, B de Andrés, B Cárdaba, A López-Farré, S Gallardo, I Cortegano, L Vidarte, A Jurado, J Sastre, P Palomino, C Lahoz.   

Abstract

Because of the involvement of nitric oxide (NO) in inflammatory states such as parasitic and hypersensitivity disorders and the fact that eosinophils are one of the cell types implicated, we asked whether eosinophils were able to express mRNA specific to inducible NO synthase (iNOS) and iNOS protein and to secrete nitric oxide. iNOS protein was detected on eosinophil preparations by immunocytochemistry using iNOS mAb. Expression of iNOS protein was also detected by immunoblotting in human purified eosinophils and an eosinophilic leukemia cell line, Eol-3. Nitrite production was detected in the supernatant of human eosinophils and Eol-3 cells cultured for 24 h, and was completely inhibited in the presence of the NOS inhibitor N-methylester-L-arginine. iNOS cDNA was obtained by reverse transcription-PCR. After subcloning, sequencing of the 259-bp fragment from three different human eosinophils cDNAs revealed 97% identity with macrophage/monocyte iNOS. Our studies describe for the first time the presence of iNOS on eosinophil and a putative new role for this cell in inflammatory states such as asthma and parasitic disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8993004

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics.

Authors:  Peter Hodsman; Claire Ashman; Anthony Cahn; Erika De Boever; Nicholas Locantore; Adrian Serone; Isabelle Pouliquen
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

2.  Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn.

Authors:  G Kristjánsson; M Högman; P Venge; R Hällgren
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Inducible nitric oxide synthase in the myocard.

Authors:  I B Buchwalow; W Schulze; P Karczewski; M M Kostic; G Wallukat; R Morwinski; E G Krause; J Müller; M Paul; J Slezak; F C Luft; H Haller
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

4.  Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.

Authors:  S R Rutgers; T W van der Mark; W Coers; H Moshage; W Timens; H F Kauffman; G H Koëter; D S Postma
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

5.  Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils.

Authors:  R C Zanardo; E Costa; H H Ferreira; E Antunes; A R Martins; F Murad; G De Nucci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Bactericidal activity of human eosinophilic granulocytes against Escherichia coli.

Authors:  T Persson; P Andersson; M Bodelsson; M Laurell; J Malm; A Egesten
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Clinical signs and hematologic, cytokine, and plasma nitric oxide alterations in response to Strongylus vulgaris infection in helminth-naïve ponies.

Authors:  Jeremy D Hubert; Thomas L Seahorn; Thomas R Klei; Giselle Hosgood; David W Horohov; Rustin M Moore
Journal:  Can J Vet Res       Date:  2004-07       Impact factor: 1.310

8.  Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase.

Authors:  Martina Ulrich; Alina Petre; Nikolay Youhnovski; Franziska Prömm; Markus Schirle; Michael Schumm; Ralph S Pero; Alfred Doyle; James Checkel; Hirohito Kita; Nethaji Thiyagarajan; K Ravi Acharya; Peter Schmid-Grendelmeier; Hans-Uwe Simon; Heinz Schwarz; Masato Tsutsui; Hiroaki Shimokawa; Gabriel Bellon; James J Lee; Michael Przybylski; Gerd Döring
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

9.  Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.

Authors:  S A Kharitonov; L E Donnelly; P Montuschi; M Corradi; J V Collins; P J Barnes
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

10.  Associations between nitric oxide synthase genes and exhaled NO-related phenotypes according to asthma status.

Authors:  Emmanuelle Bouzigon; Florent Monier; Mekki Boussaha; Nicole Le Moual; Hélène Huyvaert; Régis Matran; Sébastien Letort; Jean Bousquet; Isabelle Pin; Mark Lathrop; Francine Kauffmann; Florence Demenais; Rachel Nadif
Journal:  PLoS One       Date:  2012-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.